about
Host-Specific and Segment-Specific Evolutionary Dynamics of Avian and Human Influenza A Viruses: A Systematic ReviewAptamers in diagnostics and treatment of viral infectionsRisk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivirEpitope specific T-cell responses against influenza A in a healthy population.Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water.Drug resistance in influenza A virus: the epidemiology and management.Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.Mast cells and influenza a virus: association with allergic responses and beyond.BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study.Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination.An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.The pandemic potential of avian influenza A(H7N9) virus: a review.Genetic Predisposition To Acquire a Polybasic Cleavage Site for Highly Pathogenic Avian Influenza Virus Hemagglutinin.Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus.The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In VitroDifferential Biphasic Transcriptional Host Response Associated with Coevolution of Hemagglutinin Quasispecies of Influenza A VirusProtective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus.Novel real-time PCR-based patho- and phylotyping of potentially zoonotic avian influenza A subtype H5 viruses at risk of incursion into Europe in 2017.Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017.Avian influenza in Latin America: A systematic review of serological and molecular studies from 2000-2015.Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials.Sialic acid-binding protein Sp2CBMTD protects mice against lethal challenge with emerging influenza A (H7N9) virusInfluenza virus reservoirs and intermediate hosts: dogs, horses, and new possibilities for influenza virus exposure of humans.Role of siglecs and related glycan-binding proteins in immune responses and immunoregulationRecombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Susceptibility of bone marrow-derived macrophages to influenza virus infection is dependent on macrophage phenotype.Ecto-5'-nucleotidase CD73 modulates the innate immune response to influenza infection but is not required for development of influenza-induced acute lung injury.Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.Capture and characterization of influenza A virus from primary samples using glycan bead arrays.Early clearance of Chikungunya virus in children is associated with a strong innate immune response.Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in MiceHighly sensitive detection of influenza virus by boron-doped diamond electrode terminated with sialic acid-mimic peptide.Single PA mutation as a high yield determinant of avian influenza vaccines.Single-virus force spectroscopy unravels molecular details of virus infection.Influenza A Virus Dysregulates Host Histone Deacetylase 1 That Inhibits Viral Infection in Lung Epithelial CellsThe PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.Polymeric therapeutic delivery systems for the treatment of infectious diseases.
P2860
Q26772139-5BBE4C02-C539-4D91-8154-3B1AD4E24964Q27014527-96521033-837B-441C-8034-64965BE79449Q28066861-E4795B46-38AC-47EF-82B8-A46331E8D127Q30202358-36DAB5D8-63F0-4F93-BA08-2E107BC25A14Q30202859-CB79DB06-6D59-46E1-90BA-0674B638B814Q30203367-EDA876E8-3D06-420C-B39C-2EE3611E9600Q30234600-039E0275-E3F0-43CE-BAC3-85D9AD5E51D9Q30369353-CC364A36-E3D5-4927-BCF1-56201E6FDDB5Q30375297-EE35938C-B737-4829-8113-3E52F6FAB6EBQ30375629-AC513108-F734-4E46-AF38-E3B18BEB1DD8Q30375754-9FE6CB45-FA77-40F4-910E-B14CE5C0DB3FQ30377023-AF922E14-5930-446F-86FD-2937677BB0BEQ30377088-7C03DD58-27CE-4B8C-B37C-A467CA5F8CDBQ30378750-FAAF064D-5778-4FD4-81ED-C8594C7D5C99Q30386537-EA1AB00D-CF1D-43E4-AB58-11A9687F5AA4Q30387177-72707839-AEB4-4B0B-A210-9C3D53BB1D39Q30390167-54D8928B-9F81-4187-B4C4-1AED8F42E370Q30391945-AF76840F-7F02-4919-AA93-95B524B59A9CQ30397362-3B4A910C-6071-4B4F-8AD1-B56E4B97C615Q30397410-4E8817AF-12AC-4F4D-B9E8-6C8D2D3B8CACQ33553156-5F433C70-BF99-48CF-9EB9-4C12A0F49CB2Q33813994-AA348AE2-A2DA-4C6C-8662-2EB5BC626F37Q33817436-DE8DB17A-264D-4330-AE65-BBC4B7B39476Q34485005-58536710-2C3B-4932-B87E-F9A38C4305E1Q35076835-38137754-6F66-4FB3-B48A-281A991FFEFBQ35110996-9E7243EE-7922-4B02-BBB3-F290BD423D46Q35164415-5C268576-CCF7-45A5-9F6B-EB9BB7A21AE8Q36023082-5391E292-ECED-4496-9009-FD61954A8F07Q36255054-F2593DBC-7D43-4055-BA9D-7FE4B613467FQ36345859-9B41A804-92D1-4D47-AA71-5AF05E9EAE7BQ36791678-79E7BF59-4157-41DF-AC2C-22ADB6C58572Q36880176-50343054-474D-4BC3-98CE-0B3290185293Q36903227-4DF57093-05E3-4F48-B8B5-C751CE6AD9E5Q36934209-ED280F13-C6AE-41B9-BC6D-039AC886A9D6Q37181772-358872A5-1308-4ECA-95FF-DEC5D57706A1Q37584477-C3676DA0-10AF-4E77-994F-D98FC08B1A19Q38448983-B2FAD496-1635-456D-9B62-E379DCF5D5B3Q38791236-BA9B7992-68F8-4E80-85C7-61A4091F64B7Q38963385-B8FD6CE8-C9CD-43C7-AF4F-842A82B5D2B7Q39386505-9961D115-AC91-4A4C-8478-E0876F821EC6
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Continuing challenges in influenza.
@ast
Continuing challenges in influenza.
@en
type
label
Continuing challenges in influenza.
@ast
Continuing challenges in influenza.
@en
prefLabel
Continuing challenges in influenza.
@ast
Continuing challenges in influenza.
@en
P2860
P356
P1476
Continuing challenges in influenza.
@en
P2093
Robert G Webster
P2860
P304
P356
10.1111/NYAS.12462
P407
P577
2014-05-30T00:00:00Z